Psychiatric University Hospital Zurich

What Psychiatric University Hospital Zurich does

Psychiatrische Universitätsklinik Zürich (PUK), founded in 1870 and operating as an independent public-law institution of the Canton of Zurich since January 1, 2018, is one of Europe's largest university psychiatric hospitals. The clinic is structured around four clinical departments — Child and Adolescent Psychiatry and Psychotherapy, Adult Psychiatry and Psychotherapy, Geriatric Psychiatry and Psychotherapy, and Forensic Psychiatry and Psychotherapy — that collectively deliver inpatient, day-clinic, outpatient, home-treatment, and 24/7 emergency psychiatric services across the Canton of Zurich. With roughly 2,700 employees spanning more than 50 professions and approximately 12 locations (including a headquarters at Lenggstrasse 31, the forensic center in Rheinau, eight regional outpatient clinics for child/adolescent psychiatry across Canton Zurich, and the new 'im Quadro' outpatient center opened in Zurich-Oerlikon in April 2025), PUK served patients at a 98.9% inpatient occupancy rate in FY2025.

The hospital's service portfolio spans established modalities (psychotherapy, pharmacotherapy, ECT, rTMS, es-ketamine, N2O inhalation), specialized programs (Second Opinion Depression clinic, Supported Employment, Crisis Intervention/KIZ, Home Treatment, forensic assessment), and novel treatment research including psilocybin-assisted therapy for treatment-resistant depression (published in The Lancet Regional Health Europe) and the NEKTAR study combining ketamine with neurofeedback for alcohol dependence, funded by the Wellcome Leap Foundation. Digital therapeutic tools (the 'Ricky und die Spinne' computer game for pediatric tic/OCD) and the Lifegarden outdoor resilience training parcours — developed with the University of Zurich — extend the offering into preventive and digital mental health.

PUK operates under a regulated, multi-stream revenue model: services are reimbursed under the Swiss Krankenversicherungsgesetz (KVG) via TARMED tariffs for outpatient care and Swiss DRG for inpatient care, supplemented by cantonal subsidies from the Canton of Zurich for public-health mandates (forensic psychiatry, crisis services, training) and grants from international research funders. The clinic is governed by a Spitalrat (hospital council) appointed by the cantonal government, with senior leadership including CEO Markus Merz, Deputy CEO Markus Voegeli, and four department directors (Prof. Erich Seifritz for Adult Psychiatry, Prof. Susanne Walitza for Child/Adolescent, Prof. Egemen Savaskan for Geriatric, Prof. Elmar Habermeyer for Forensic). Academic affiliation with the University of Zurich anchors teaching and translational research, and the hospital pursues capital-intensive modernization through the Lengg new construction project and the Rheinau forensic expansion (39 medium-security inpatient places).

Name

Psychiatric University Hospital Zurich

Legal name

Psychiatrische Universitätsklinik Zürich

Website

https://pukzh.ch

Company type

Private

Founded year

1870

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Psychiatrische Universitätsklinik Zürich (PUK) is a public-law university psychiatric hospital of the Canton of Zurich that delivers inpatient, outpatient, day-clinic, home-treatment, and forensic psychiatric services across the lifespan to the population of Canton Zurich.

Ownership category

akta.pro rank

Product category

Psychiatric Hospital Services

NAICS

Psychiatric and Substance Abuse Hospitals (62221), Outpatient Mental Health and Substance Abuse Centers (621420), Residential Mental Health and Substance Abuse Facilities (623220)

SIC

Services-Health Services (8000), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Inpatient Psychiatric Hospitals (HLAFAHAH)

akta.pro secondary industries

Outpatient Mental Health Clinics & Counseling Centers (HLAFACAA), Behavioral Health for Children & Adolescents (Youth Services) (HLAFACAL), Residential Mental Health Treatment Centers (HLAFACAC), Outpatient Mental Health & Counseling Clinics (HLAFABAC)

Keywords

• Psychiatric hospital services
• Mental health treatment
• Child adolescent psychiatry
• Forensic psychiatry services
• Psychiatric emergency care

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices12 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Health Insurance Reimbursement (KVG): Psychiatric treatments are covered by mandatory Swiss basic health insurance (Krankenversicherungsgesetz/KVG) plus supplementary insurance. Outpatient and inpatient psychiatric care is reimbursed according to Swiss DRG/tariff systems.
2. Cantonal Government Subsidies: As a public psychiatric university hospital, PUK receives cantonal subsidies from the Canton of Zurich for fulfilling public healthcare obligations including forensic psychiatry, crisis services, and training functions.
3. Research Grants and Clinical Studies: International research funding including Wellcome Leap Foundation grants for clinical trials such as the NEKTAR study on alcohol dependence treatment. Revenue from research activities and clinical trials.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels4 records

Core offering

Psychiatrische Universitätsklinik Zürich operates as a comprehensive psychiatric university hospital providing psychiatric and psychotherapeutic treatment across the entire lifespan through four departments: Child and Adolescent Psychiatry, Adult Psychiatry, Geriatric Psychiatry, and Forensic Psychiatry. Services span outpatient clinics, day clinics, inpatient wards, home treatment, and 24/7 crisis intervention, supplemented by specialized programs including psilocybin-supported therapy, ketamine/S-ketamine treatment, electroconvulsive therapy, supported employment, and the Lifegarden resilience training parcours.

Product overview

The Psychiatrische Universitätsklinik Zürich operates as a unified psychiatric hospital system with four main departments (Child/Adolescent, Adult, Geriatric, and Forensic Psychiatry) offering comprehensive mental health services across the lifespan. The hospital provides core psychiatric treatment services supplemented by specialized treatment programs including advanced therapies like psilocybin-supported therapy, ketamine/S-ketamine treatment, and electroconvulsive therapy through its Second Opinion Depression clinic. Support services include Supported Employment for vocational integration, crisis intervention (KIZ), home treatment, and the Lifegarden outdoor resilience training programme. The hospital also offers digital therapeutic tools like the Ricky und die Spinne computer game for children with tic disorders.

Differentiator

Problem solved

Functional benefit

Products and services

• Kinder- und Jugendpsychiatrie und Psychotherapie (Child and Adolescent Psychiatry) Comprehensive psychiatric and psychotherapeutic services for children and adolescents up to age 18, delivered through eight regional outpatient clinics, day clinics, inpatient wards, crisis intervention, and home treatment across Canton Zurich. Treats anxiety disorders, ADHD, autism, eating disorders, psychosis, trauma, tic and OCD disorders, and substance use.
• Erwachsenenpsychiatrie und Psychotherapie (Adult Psychiatry) Comprehensive psychiatric and psychotherapeutic services for adults aged 18-65, covering addiction, ADHD, anxiety, autism, bipolar disorders, depression, eating disorders, personality disorders, psychosis, stress and trauma disorders. Includes specialized programs such as Supported Employment, Living Environment support, and Home Treatment.
• Alterspsychiatrie (Geriatric Psychiatry) Psychiatric services for adults aged 65+ treating addiction, anxiety, delirium, dementia, depression, memory disorders, and sleep disorders. Delivered through outpatient services, the Memory Clinic, day clinic, inpatient wards, and home treatment.
• Forensische Psychiatrie und Psychotherapie (Forensic Psychiatry) Forensic psychiatric services for mentally ill offenders of all ages, including inpatient and outpatient treatment, assessment, prevention and threat management, and prison psychiatric services, along with specialized programs such as ForTiS, ThePaS, TESOK, and RADIP.
• Ambulatorium Second Opinion Depression (Second Opinion Depression Clinic) Specialized outpatient clinic offering diagnostic second opinions and consultation for treatment-resistant depression, with comprehensive diagnostics including MRI/CT imaging and EEG, plus specialized treatments such as rTMS, ECT, es-ketamine, N2O inhalation, and psilocybin therapy.
• Elektrokonvulsionstherapie (ECT) Electroconvulsive therapy delivered as part of the Second Opinion Depression clinic for patients with severe, treatment-resistant depression.
• Psilocybin-unterstützte Therapie (Psilocybin-Supported Therapy) Psilocybin-assisted therapy for severe depressive episodes, administered in a protected group setting with 3-5 patients as part of a comprehensive multimodal program; requires exceptional approval from the Federal Office of Public Health.
• Behandlung mit Ketamin und S-Ketamin (Ketamine and S-Ketamine Treatment) Treatment using approved S-ketamine (Spravato) or racemic ketamine for treatment-resistant depression, including pre-assessment, diagnostic examinations, and supervised administration twice weekly.
• Supported Employment Employment support service with approximately 8-10 job coaches that helps people with mental health problems maintain or find employment, including job search support, assistance with workplace difficulties, and return-to-work support after hospitalization.
• Krisenintervention (KIZ) Crisis intervention service offering outpatient crisis intervention or inpatient stays of up to seven days for acute crisis resolution in a voluntary and open-setting environment.
• Lifegarden – Resilienzparcours (Resilience Parcours) Outdoor resilience training parcours with five interactive stations based on scientific findings from the University of Zurich, providing practical exercises to promote mental resilience and prevent mental illness. Open to the public.
• Computerspiel Ricky und die Spinne (Computer Game Ricky and the Spider) Interactive computer game for children with tic and obsessive-compulsive disorders that delivers a therapeutic intervention through engaging gameplay.

Quantifiable outcome

• 98.9% stationary occupancy rate demonstrating high demand and capacity utilization
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Universität ZürichcoreStrategic or Co-development Partner · 1 November 2025Academic affiliation as a University Psychiatric Hospital. The clinic serves as the clinical division of the University of Zurich's psychiatric faculty, integrating teaching and research with patient care. Joint professorship appointments and collaborative research programs including the Lifegarden resilience project and translational psychiatry research.
• Blumer LehmannminorStrategic or Co-development Partner · 1 November 2025Timber construction company that collaborated on the Lifegarden resilience training parcours development. The outdoor installation represents an innovative citizen-science approach to mental health prevention.
• Spitalrat Canton ZürichcoreOthersThe Spitalrat (hospital council) is the supreme strategic governing body of PUK, appointed by the Canton of Zurich government. The cantonal parliament approves appointments and the clinic receives public mandates for psychiatric care provision.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• McLean Hospital: Harvard Medical School-affiliated psychiatric hospital offering specialized inpatient and residential programs across the lifespan. Comparable in academic affiliation, research output, and pioneering role in psychiatric treatment innovation including depression and addiction.
• Universitätsklinikum Heidelberg – Klinik für Allgemeine Psychiatrie: Major German university psychiatric hospital with strong translational research focus and lifespan service coverage. Comparable as a public-academic psychiatric center with cutting-edge treatment programs including ketamine and TMS for treatment-resistant depression.
• Universitäre Psychiatrische Dienste Bern (UPD): Public academic psychiatric hospital affiliated with the University of Bern, providing inpatient, outpatient, and forensic psychiatry across the lifespan. Direct Swiss peer operating under a similar cantonal mandate, KVG reimbursement model, and university hospital structure.
• Karolinska University Hospital – Department of Psychiatry: Sweden's largest university hospital with a dedicated psychiatry department providing lifespan mental health care and research. Comparable as a publicly funded academic institution delivering advanced psychiatric services with strong international research collaborations.
• Psychiatrische Dienste Aargau (PDAG): Cantonal psychiatric services provider for Aargau offering inpatient, outpatient, and forensic psychiatry comparable in scope to PUK. Operates under similar Swiss public-law governance, KVG/DRG tariffs, and university-affiliated research mandate.
• Charité – Universitätsmedizin Berlin (Department of Psychiatry): One of Europe's largest university hospitals with a major Department of Psychiatry and Psychotherapy providing full-lifespan care, translational research, and novel therapies (including psychedelics). Comparable in scale (~300,000+ inpatient cases/year combined), academic scope, and pioneering treatment programs.
• Universitätsklinikum München (LMU Klinikum) – Department of Psychiatry: Major German university hospital with a large Department of Psychiatry and Psychotherapy providing full-lifespan mental health care and translational research. Comparable in scale, academic affiliation, lifespan service coverage, and emphasis on novel treatment development.
• South London and Maudsley NHS Foundation Trust (SLaM): UK's largest mental health provider affiliated with the Institute of Psychiatry, Psychology & Neuroscience (King's College London). Comparable in combining clinical care, world-class research, and specialized programs for depression, psychosis, and addiction across inpatient and community settings.

Regional players

• Hôpitaux Universitaires de Genève (HUG): Swiss public university hospital in Geneva with psychiatric services, sharing the same national KVG reimbursement system and academic hospital operating model. Comparable as another large publicly funded Swiss university hospital, though PUK is significantly more specialized in psychiatry.
• Universitätsspital Zürich (USZ): Switzerland's largest university hospital based in the same city as PUK. Regional peer operating under identical KVG/DRG reimbursement framework with overlapping academic affiliation to the University of Zurich; provides liaison psychiatry but focuses on somatic specialties.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/pukzh

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Psychiatric University Hospital Zurich